Four choline esters of imidazole acids, two imidazole ethers of choline and thirteen ringsubstituted murexine-like compounds were compared with murexine for their muscle-paralysing and their nicotine-like effects. Dihydromurexine appeared, in animal experiments, to be the most potent derivative, but it was shown to be less effective than murexine in man. Among the other compounds, imidazolebutyrylcholine and imidazolepropoxycholine appeared to be worthy of particular consideration. The relation between the chemical structure of the murexine-like substances studied and their pharmacological effects is discussed.
The main pharmacological properties of murexine (urocanoylcholine, [2-fl-imidazol-4'(59-ylacryloyloxyethyl] trimethylammonium chloride hydrochloride), a naturally occurring neuromuscular blocking agent found in the hypobranchial body of some prosobranchiate molluscs, have been described in previous papers by ourselves (Erspamer and Glasser, 1957) and others Quilliam, 1957; Winbury, 1957; Keyl and Whittaker, 1958) .
The investigations described below are concerned with some pharmacological effects of 19 murexine-like derivatives, synthesized by Pasini, Vercellone, and Erspamer (1956) and by Pasini and Coda (1957) . Four are murexine analogues (choline esters of imidazole acids), two are imidazole ethers of choline, and 13 are choline esters of acrylic or propionic acids substituted in the /3-position with heterocyclic rings different from the imidazole ring.
A few comparative experiments were also carried out with fBf-dimethylacryloylcholine or senecioylcholine, a new choline ester recently discovered by Whittaker (1957) in the marine gastropod Thais floridana.
METHODS AND MATERIALS Murexine Samples.-Synthetic murexine chloride hydrochloride was used throughout the experiments for comparison. Murexine samples were always synthesized shortly before use because the activity of crystalline murexine chloride hydrochloride has been obsepved to decrease slowly on standing, apparently by as much as 50%. This puzzling fact, not yet fully elucidated by the studies of Pasini and Coda (1957) , of course impairs the accuracy of the comparison of murexine with the other substances. The absolute and relative values reported in this paper should, for this reason, be regarded as only approximate. As it was not known whether the derivatives, like murexine, lost activity on standing, they were all freshly synthesized before use.
Pharmacological Methods.-The pharmacological methods used in the present investigation were identical with those previously described (Erspamer and Glasser, 1957) .
Neuromuscular blocking action was tested in the intact animal and on the cat sciatic nerve-gastrocnemius muscle preparation, prepared in the manner described by Burn (1950) . The doses required to cause head-drop in 50% of rabbits and to paralyse 50% of dogs were determined after rapid intravenous injection. In the cat sciatic nerve-gastrocnemius muscle preparation, maximal stimuli (rectangular current pulses of 7 msec. duration) were applied to the sciatic nerve through a unipolar electrode at a rate of 5 or 10/min. and the contractions were recorded semi-isometrically. Cats were anaesthetized with chloralose (70 mg./kg., i.v.) and the injections were given into the femoral vein. Blood pressure was recorded from the carotid artery. Respiration was recorded by means of a tracheal cannula connected to a tambour. Adequate oxygenation of the blood during apnoea was maintained by a respiratory pump.
Rabbits received intravenous injections into the ear marginal vein, mice into the tail vein.
Muscarine-like action was tested on the rabbit intestine and on the rabbit atrium. The isolated frog rectus abdominis muscle and the blood pressure of Table I shows the relative potency of the six new compounds compared with that of murexine.
Some absolute values, expressed in mg. free base/ kg. body weight, are given in parentheses.
In Table II the paralysing doses in the cat gastrocnemius preparation of murexine (I) are compared with those of the other compounds.
Other pharmacological effects of the substances examined are as follows:
Imidazoleacetylcholine.-Like murexine, imidazoleacetylcholine (2-imidazol-4'(5')-ylacetoxyethyltrimethylammonium) elicited variable blood Winbury (1957) and Roth, Rubin, ! Tabachnick, and Govier (1958) , that hexamethonium (2 to 3 mg./kg., i.v.) reduced or abolished only the hypertension, whereas atropine (1 mg./ kg., i.v.) eliminated the fall of blood pressure and heart rate. On the other hand, eserine salicylate (50 ,tg.1kg., i.v.) enhanced the rise of pressure in the spinal cat, the size of which (Table I and Fig. 1 ) was approximately one quarter of that produced by murexine. Similarly, eserine enhanced and prolonged the.neuromuscular block exerted by imidazoleacetylcholine in the cat gastrocnemius preparation (Fig. 3) . 
ilj-Dimethylacryloylcholine Ring-substituted Murexine-like Compounds Table III shows the relative potency, on a molar basis, of the ring-substituted compounds, with respect to murexine.
The duration of the neuromuscular block was very short for all substances in this series. Following abolition of the twitch, 50% recovery was generally observed in 2 to 3 min. (Figs. 4 and  5) . Hence, the compounds are rather easily inactivated in the organism.
On the rabbit atrium, both the pyrirnidin-4-yl derivatives were ineffective up to concentrations of 20 ug./ml.; 8--pyrid-2-ylacryloylcholine showed, at the same dosage, a slight negative chronotropic effect and, occasionally, a slight positive inotropic effect. Keyl, Michaelson, and Whittaker (1957) examined other ring-substituted choline esters and found that, on the frog rectus preparation, indolylacetylcholine manifested the same stimulant effect as murexine, indolylpropionylcholine 60%, and nicotinylcholine 10% of the effect of murexine. Our investigations confirm their statement that /3/-dimethylacryloylcholine has a very strong nicotinic action, in addition to its remarkable muscle-paralysing effect.
DISCUSSION
The experiments described in this paper were carried out with the main purpose of throwing some light on the problem of the relation between the chemical structure and pharmacological actions of murexine derivatives.
Concerning the first series of the murexine-like compounds examined (the imidazole esters and imidazole ethers of choline) the following conclusions may be drawn from the experimental results:
(a) Hydrogenation of the acryloyl side-chain into propionyl caused, as a rule, a powerful increase in both nicotinic and neuromuscular blocking actions. In rabbits, cats, and dogs dihydromurexine was as active as, or even more active than, suxamethonium in producing paralysis of the skeletal musculature. On the frog rectus abdominis dihydromurexine was nearly as potent as acetylcholine in causing contracture.
A remarkable exception is man, for whom the drug is less active than murexine as a musclerelaxant agent. In fact, in preliminary experiments carried out by De Blasi and Leone (personal communication), dihydromurexine, given by slow intravenous injection in doses up to 1 g., failed to produce consistent muscular relaxation. The reason for this has been explained, at least in part, by the observations of Foldes, Erd6s, Baart, and Shanor (1957) and Grelis and Tabachnick (1957) , who demonstrated that, whereas murexine is slowly hydrolysed by human plasma cholinesterase, the rate of hydrolysis of dihydromurexine is as fast as that of acetylcholine and 18 times faster than that of murexine. (b) The length of the side-chain of the imidazole acid was of critical importance. A three carbon atom chain seemed to be optimal both for maximal blocking and nicotinic potency. Imidazoleacetyl-and imidazolecarboxyl-choline on the one hand and imidazolebutyrylcholine on the other were less potent than dihydromurexine. Imidazolecarboxylcholine was the least active member of the series, having a paralysing action barely 1 % of that of dihydromurexine.
( (Fig. 2 ) and 300 to 500 times less effective on the frog rectus abdominis. Both the ethers were more toxic in the mouse than the corresponding esters; it was, however, doubtful whether peripheral respiratory arrest was the only cause of death.
(d) Muscarinic actions were very weak, if present, in all compounds of this series. When compared to that of acetylcholine, the spasmogenic action on the rabbit colon was less than 1/10,000 to 1/50,000, the action on the rabbit atrium less than 1 %, and the vasodilator action on the dog leg approximately 1% to 2% (Winbury et al., 1957 and Winbury, 1957) .
From Table I recovery from a given twitch reduction may vary consistently for the different compounds. In this respect, imidazoleacetylcholine (Fig. 3) and imidazolebutyrylcholine produced the shortest neuromuscular block, imidazolepropoxycholine the longest (Fig. 2) .
As for the nicotinic effects, the most interesting fact is a frequent dissociation between the nicotinic action on ganglia and adrenal medulla (blood pressure of the spinal cat) and that on the neuromuscular junction (frog rectus abdominis). For example, imidazolecarboxylcholine and imidazolepropoxycholine possess 25% and 20%, respectively, of the activity of murexine on the cat blood pressure, but only 1% to 2% of that on the frog rectus abdominis.
With regard to the second series of our products (the ring-substituted murexine-like compounds), the observations summarized in Table III allow the conclusions: (a) that the substitution of a propionyl for the acryloyl side-chain generally causes an enhancement of both the muscleparalysing and the nicotinic actions; (b) that in the more active products the heterocyclic nucleus is linked to the acylcholine chain in such a way as to present the following sequence of atoms (Pasini et al., 1956) ; and (c) that the heterocyclic nucleus -CH /C-acylcholine chain =N is by no means necessary for the appearance of the characteristic pharmacological effects. 8,/-Dimethylacryloylcholine, the choline ester of a simple aliphatic acrylic acid, possesses at least 50% of the muscle-paralysing potency of murexine and a nicotinic effect which is twice as strong. Another object of this work was that of seeking a product which could be employed, more advantageously than murexine, as an adjuvant in anaesthesia. In fact the advisability of adopting murexine clinically as a muscle relaxant has yet to be established.
The present investigation was virtually unsuccessful in indicating a possible substitute for murexine. Dihydromurexine, which at first seemed on the basis of animal experiments to be the most promising substitute, turned out to be practically ineffective in human beings. Unfortunately, owing to difficulties in their synthesis, imidazolebutyrylcholine and imidazolepropoxycholine could not be prepared in amounts large enough to permit a clinical trial. The substantial attenuation of the disturbing nicotinic effects on blood pressure and on skeletal musculature shown by the second substance could represent an important advantage over murexine.
The ring-substituted murexine-like compounds were not considered for clinical trial. The three or four which seemed worthy of fuller consideration presented very strong nicotinic effects, in addition to an exceedingly short duration of the muscle-paralysing action. Gruner and Kewitz (1955) have tentatively identified with imidazoleacetylcholine an imidazole derivative found by them in extracts of mammalian brain. It is interesting to note that in our experiments, as in those of Roth et al. (1958) , imidazoleacetylcholine proved to be one of the less potent of the imidazole derivatives tested. It should be added that Correale (1958) was unable to detect imidazoleacetic acid or imidazoleacetylcholine in brain extracts of lower vertebrates, but succeeded in demonstrating, by paper chromatography, the occurrence of enormous amounts (apparently up to 600 to 800 jug. /g. fresh tissue) of another unknown imidazole derivative. This is similar, in many respects, to imidazoleacetic acid and imidazolepropionic acid and, therefore, could perhaps be identical with the imidazole compound obtained by Gruner and Kewitz (1955) following hydrolysis of their new choline ester.
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